, Cas9 also functions as a powerful genome engineering tool in plants and animals [4] [5] [6] , and efforts are underway to increase the efficiency and specificity of DNA targeting for potential therapeutic applications 7, 8 . Studies of off-target effects have shown that DNA binding is far more promiscuous than DNA cleavage [9] [10] [11] , yet the molecular cues that govern strand scission have not been elucidated. Here we show that the conformational state of the HNH nuclease domain directly controls DNA cleavage activity. Using intramolecular Förster resonance energy transfer experiments to detect relative orientations of the Cas9 catalytic domains when associated with on-and off-target DNA, we find that DNA cleavage efficiencies scale with the extent to which the HNH domain samples an activated conformation. We furthermore uncover a surprising mode of allosteric communication that ensures concerted firing of both Cas9 nuclease domains. Our results highlight a proofreading mechanism beyond initial protospacer adjacent motif (PAM) recognition 12 and RNA-DNA base-pairing 3 that serves as a final specificity checkpoint before DNA double-strand break formation.
, and sgRNA/DNA-bound 15, 16 Cas9 from Streptococcus pyogenes (Fig. 1a, b ) have revealed distinct conformational states of the protein but failed to explain its DNA cleavage mechanism, because in each structure the HNH domain active site is positioned at least 30 Å away from the DNA cleavage site 15, 16 . Furthermore, available structures could not explain why DNA cleavage is precluded at stably bound off-target sites with incomplete RNA-DNA complementarity. We hypothesized that functionally important HNH conformational dynamics could influence the cleavage specificity of the Cas9-guide RNA enzyme complex. To test this possibility, we developed a Förster resonance energy transfer (FRET)-based approach to investigate Cas9 structural changes in response to binding sgRNA and DNA ligands.
We generated a FRET construct to monitor Cas9 structural rearrangements upon sgRNA binding 13 ( Fig. 1b) . Starting with a cysteine-free Cas9 variant, we introduced cysteine residues at positions D435 and E945 near the hinge region and labelled these residues with Cy3-and Cy5-maleimide dyes, generating Cas9 hinge . Control labelling reactions with cysteine-free Cas9 confirmed the conjugation specificity, and doubly labelled Cas9 was fully functional for DNA cleavage (Extended Data Fig. 1a-c) . Measurements from available structures revealed an expected distance change of ~60 Å upon sgRNA and DNA binding (Extended Data Table 1) , and indeed, when Cy3 of sgRNA-bound Cas9 hinge was excited at 530 nm, we observed a substantial decrease in energy transfer compared with apo-Cas9 hinge , as evidenced by a relative increase in donor (Cy3) fluorescence relative to acceptor (Cy5) fluorescence (Fig. 1c) . The observed change scaled with the molar ratio of sgRNA to Cas9, a mixture of donor-only and acceptor-only labelled Cas9 hinge showed no evidence of energy transfer, and an sgRNA specific to Neisseria meningitidis Cas9 (ref. 17) , which significantly impairs S. pyogenes Cas9 binding (data not shown), elicited a negligible change (Extended Data Fig. 2a-c) . We conclude that the change in fluorescence intensities resulted from an sgRNA-induced, intramolecular conformational change in Cas9 hinge .
Cas9 hinge exhibited an ~70% decrease in energy transfer upon sgRNA binding as determined by (ratio) A , whereby the acceptor fluorescence intensity via energy transfer is normalized to that via direct excitation 18, 19 (Methods and Extended Data Fig. 2d ). Target DNA binding induced little further change in FRET (Fig. 1c, d ), consistent with available structural data (Extended Data Table 1 ). To identify the molecular 1 Department of Chemistry, University of California, Berkeley, California 94720, USA. 2 Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, USA. 3 Howard
Hughes Medical Institute, University of California, Berkeley, California 94720, USA. 4 Innovative Genomics Initiative, University of California, Berkeley, California 94720, USA. 5 Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA. †Present address: Department of Bioengineering, Stanford University, Stanford, California 94305, USA. determinants that trigger conformational rearrangement of Cas9, we tested truncated variants of the sgRNA (Extended Data Table 2 ) and found that the 20-nucleotide target recognition sequence has a critical role in controlling the Cas9 conformational state (Fig. 1d ). An sgRNA lacking the entire guide segment (Δ guide1-20) generated a (ratio) A value indistinguishable from apo-Cas9 hinge while being more than 95% bound under our experimental conditions 14 , whereas sgRNAs containing part of the 20-nucleotide guide segment partly restored the change in (ratio) A . sgRNA variants lacking one or both hairpins at the 3′ end (Δ hairpins1-2) also generated intermediate (ratio) A values ( Fig. 1d ) while retaining sub-nanomolar binding affinity to Cas9 (ref. 20) , and similar data were obtained with catalytically dead (D10A/H840A) dCas9hinge (Extended Data Fig. 2e ). We conclude that motifs at both ends of the sgRNA are required to stabilize a closed state of Cas9, but that in the case of Δ hairpins1-2, a fully closed state is not required for rapid cleavage kinetics 20 . We propose that intermediate (ratio) A changes reflect stable sgRNA-Cas9 hinge complexes interconverting between open and closed conformers.
We next focused on the HNH nuclease domain. Since existing crystal structures exhibit inactive HNH domain conformations 15, 16 , we built a model for the putative activated state by docking a homologous HNH-dsDNA crystal structure 21 onto the sgRNA/DNA-bound Cas9 structure (Extended Data Fig. 3a-d) . We selected two pairs of positions (S355-S867 and S867-N1054) whose inter-residue distances, according to our model, would change substantially upon target DNA binding (Fig. 2a, Extended Data Fig. 3e and Extended Data Table 1 ). Cas9 labelled with Cy3 and Cy5 at these sites (Cas9 HNH-1 and Cas9 HNH-2 ) retained nearly wild-type DNA cleavage activity (Extended Data Fig. 1c) .
We observed a substantial FRET increase for catalytically inactive dCas9 HNH-1 upon target DNA binding relative to sgRNA alone (Fig. 2b) , and control experiments with non-target DNA or off-target DNA substrates containing either PAM or seed mutations failed to generate this change (Fig. 2b and Extended Data Table 2 ). We next monitored FRET with off-target DNA substrates containing mutations distal from the PAM, which retain high-affinity Cas9 binding 12, 22 . Remarkably, the observed (ratio) A values decreased as the number of mismatches increased (Fig. 2c) , and these changes were not attributable to decreasing occupancy of the sgRNA/DNA-bound complex: direct binding assays indicate at least 89% of the dCas9 HNH-1 population should be bound to all tested DNA substrates, and increasing the concentration of dsDNA had no discernible effect on (ratio) A (Extended Data Fig. 4a, b) . Our results show that the HNH domain samples a conformational equilibrium with on-target DNA that is distinct from partly matching off-target DNA, and suggest that the high FRET state corresponds to an active HNH conformation at the cleavage site.
We suspected that altered conformational states of the HNH domain could explain which off-target DNA substrates are cleaved by Cas9. Substrates with at least 4 base-pair (bp) mismatches that elicited a low (ratio) A value were cleaved slowly, if at all ( Fig. 2d and Extended Data Fig. 4c ), as observed previously 22, 23 . This indicates that the inability to access the high FRET state associated with an activated HNH conformation precludes cleavage. Interestingly, substrates with only 1-3 bp mismatches at the distal end of the target sequence were cleaved at near wild-type rates despite having diminished (ratio) A values relative to the on-target. This suggests that rapidly interconverting conformational states, one of which is the activated state, may still enable rapid cleavage. Truncated sgRNAs with shorter regions of target complementarity that exhibit enhanced fidelity in genome editing experiments 24 may similarly facilitate efficient on-target cleavage without stabilizing an activated HNH conformation. Single-molecule experiments will be necessary to reveal these putative dynamics, which are unavoidably averaged in our ensemble measurements.
We observed a similar pattern of (ratio) A changes using catalytically active Cas9 HNH , and the opposite trend of (ratio) A changes was observed with Cas9 HNH-2 , a construct designed to undergo a high-to-low FRET efficiency transition upon on-target DNA binding ( Fig. 2e and Extended Data Figs 3e and 4d). These data suggest that positioning of the HNH domain is largely unaffected by actual strand scission, but instead reflects a conformational equilibrium that is particularly sensitive to RNA-DNA heteroduplex formation at the distal end of the target. These observations emphasize the importance of RNA-DNA complementarity throughout the target region, rather than only the seed sequence closest to the PAM, in controlling Cas9 cleavage specificity.
The HNH and RuvC nuclease domains cleave target and non-target strands 3 bp upstream of the PAM, respectively 3, 25 . For partly unwound off-target substrates with mismatches >10 bp further upstream, target strand cleavage is precluded by conformational control of the HNH domain. However, the mechanism by which RuvC domaincatalysed non-target strand cleavage is avoided remains unknown. We hypothesized that this activity would be sensitive to HNH domain conformational changes. We first separately measured HNH and RuvC domain cleavage rates for a panel of partly mismatched substrates and found that both strands were consistently cleaved in synchrony (Fig. 3a, b and Extended Data Fig. 5a , b). We next used shorter DNA substrates with or without internal mismatches, such that Cas9-mediated DNA unwinding up to the site of an sgRNA-DNA mismatch would theoretically present identical substrates to the RuvC domain active site (Fig. 3a) . After separately measuring non-target strand cleavage kinetics and Cas9 HNH-1 FRET, we observed a tight correlation between RuvC domain cleavage activity and the presence of an activated HNH conformational state ( Fig. 3c and Extended Data Fig. 5c-e) . This finding provides strong evidence that HNH conformational dynamics exert allosteric control over the RuvC nuclease domain. Furthermore, the RuvC domain could still effectively cleave the non-target strand of a bubbled substrate that induced an activated HNH conformation, but whose target strand could not be cleaved by the HNH domain because of mismatches in the seed (Fig. 3d, e) . Together, these data argue that HNH conformational changes, but not HNH nuclease function, trigger RuvC domain nuclease activity.
We wondered how Cas9 achieves this functional coupling. The HNH domain is inserted between RuvC domain motifs II and III, but linkers connecting both domains are consistently disordered in available crystal structures and there are relatively few inter-domain contacts 13, 15, 16 (Extended Data Fig. 6a ). We purified an HNH deletion construct, Δ HNH-Cas9 (Extended Data Fig. 6a-c) , that retained nearly wildtype DNA binding activity while being defective in non-target strand cleavage by the RuvC domain (Fig. 4a, b and Extended Data Fig. 6d) . Thus, the HNH domain is required for RuvC nuclease domain activation but is dispensable for RNA-guided DNA targeting.
Finally, we sought to identify the basis of allostery between the HNH and RuvC domains. We hypothesized that two α -helices connecting the HNH and RuvC III motifs (residues S909-N940), previously shown to adopt an extended conformation and proposed to assist the HNH domain in approaching the cleavage site 15 , were instead acting as a signal transducer (Extended Data Fig. 7a ). We introduced a series of proline residues to specifically disrupt this α -helix and found that target strand cleavage kinetics by the HNH domain were minimally affected ( Fig. 4c-e and Extended Data Fig. 7b, c) . In stark contrast, RuvC domain nuclease activity was almost completely blocked with an E923P/T924P-Cas9 mutant, and this effect could be reversed with the corresponding alanine mutations (Fig. 4d, e and Extended Data Fig. 7c ). The finding that this effect was not confined to highly conserved residues supports the idea that disruption of the helix-forming propensity of this region, and not specific point mutations, disabled the RuvC domain. We conclude that an intact extended α -helix acts as an allosteric switch to communicate the HNH conformational change to the RuvC domain and activate it for cleavage. Understanding the precise mechanism of activation will probably require additional structures of Cas9 in a pre-cleavage state, with the intact non-target strand substrate bound in the RuvC active site. f W T R 9 1 9 P /Q 9 2 0 P E 9 2 3 P /T 9 2 4 P I9 2 7 P /T 9 2 8 P E Our data support a model in which the Cas9 endonuclease uses multiple levels of regulation to ensure accurate target DNA cleavage ( Fig. 4f and Supplementary Video 1) . After identification of potential targets via PAM binding and directional DNA unwinding dependent on sgRNA-DNA complementarity, recognition of on-target DNA drives a conformational change in the HNH nuclease domain that enables productive engagement with the scissile phosphate. Importantly, this same structural transition triggers RuvC domain catalytic activity, ensuring concerted cleavage of both DNA strands. Partly complementary off-target DNA sequences may stably bind Cas9, but by failing to drive HNH conformational changes, avoid cleavage. The recent crystal structure of sgRNA/DNA-bound Cas9 from Staphylococcus aureus (~17% sequence identity with S. pyogenes Cas9) also exhibits an inactive HNH conformation 26 , suggesting that conformational control of the HNH domain is a general feature of all Cas9 enzymes. Furthermore, this proofreading mechanism is strikingly similar to the R-loop locking mechanism used by the RNA-guided targeting complex (Cascade) from type I CRISPR-Cas systems, in which RNA-DNA heteroduplex formation at the PAM-distal end of the target exerts allosteric control over Cascade conformational rearrangements near the PAM-proximal end that are required for subsequent target cleavage 22, 27 . Beyond providing fundamental insights into the mechanism of DNA interrogation by Cas9, our findings have important implications for the use of Cas9 as a genome engineering technology. For example, our data can explain why little cleavage occurs at off-target DNA sequences identified in chromatin immunoprecipitation followed by sequencing (ChIP-seq) experiments [9] [10] [11] , and suggest that DNA nicking by the native Cas9 enzyme is disfavoured in cells owing to concerted cutting by the HNH and RuvC nuclease domains. Finally, our findings demonstrate an exciting opportunity to use protein conformational changes that report on target DNA recognition for fluorescence-based readout of DNA binding in cells.
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No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Cas9 and nucleic acid preparation. S. pyogenes Cas9 was cloned into a custom pET-based expression vector encoding an N-terminal His 10 -tag followed by maltose-binding protein (MBP) and a TEV protease cleavage site. Point mutations were introduced using site-directed mutagenesis or around-the-horn PCR and verified by DNA sequencing. dCas9 refers to catalytically inactive (dead) Cas9 containing D10A and H840A mutations. Δ HNH-Cas9 contained a deletion of residues T769-K918 and replacement with a GGSGGS linker. The HNH domain for add-back experiments (Extended Data Fig. 6d ) encoded residues N776-G907. All Cas9 variants were purified as described 13 . sgRNA templates were PCR amplified and cloned into EcoRI and BamHI sites in pUC19, and encoded full-length CRISPR RNA (crRNA) and transactivating crRNA (tracrRNA) sequences connected via a GAAA tetraloop (Extended Data Table 2 ). sgRNAs were transcribed in vitro as described 30 and purified using 5-10% denaturing PAGE.
DNA substrates (Extended Data Table 2 ) were prepared from commercially synthesized oligonucleotides (Integrated DNA Technologies). DNA duplexes without internal mismatches were prepared and purified by native PAGE as described 13 . DNA duplexes containing internal mismatches or overhangs were prepared by mixing a 5× molar excess of one strand with its complementary strand in hybridization buffer (20 mM Tris-Cl pH 7.5, 100 mM KCl, 5 mM MgCl 2 ), heating at 95 °C for 1-2 min, and slow-cooling on the benchtop. For FRET experiments, the non-target strand was in excess over the target strand; for biochemical cleavage experiments, the non-radiolabelled strand was in excess over the radiolabelled strand. Preparation of dye-labelled Cas9. Labelling reactions were conducted in Cas9 gel filtration buffer (20 mM Tris-Cl pH 7.5, 200 mM KCl, 5% glycerol, 1 mM TCEP) and contained 10 μ M Cas9 and 200 μ M Cy3-and Cy5-maleimide (GE Healthcare). Dyes were initially dissolved in anhydrous DMSO before being mixed with Cas9, and the final DMSO concentration did not exceed 5%. Reactions were incubated in the dark for 2 h at room temperature (~22 °C) followed by incubation overnight at 4 °C. Reactions were quenched by adding 10 mM DTT, and labelled Cas9 was separated from free dye by size-exclusion chromatography on a Superdex 200 10/300 column. Samples were then concentrated, snap frozen in liquid nitrogen, and stored at −80 °C. Control labelling reactions contained either cysteine-free Cas9 or only one of the two dyes. FRET experiments. All fluorescence measurements were conducted at room temperature in reaction buffer (20 mM Tris-Cl pH 7.5, 100 mM KCl, 5 mM MgCl 2 , 5% glycerol, 1 mM DTT), supplemented with 50 μ g ml −1 heparin to reduce nonspecific DNA binding 12 . Reactions (60 μ l) with Cas9 hinge (C80S/D435C/C574S/ E945C-Cas9 labelled with Cy3/Cy5) and dCas9 hinge (Cas9 hinge with additional nuclease-inactivating D10A/H840A mutations) contained either 50 nM or 100 nM Cas9, and, when present, a 10× and 4× molar excess of sgRNA and target DNA, respectively. Reactions (60 μ l) with Cas9 HNH-1 (C80S/S355C/C574S/S867C-Cas9 labelled with Cy3/Cy5), dCas9 HNH-1 (Cas9 HNH-1 with additional nucleaseinactivating D10A/H840A mutations), and Cas9 HNH-2 (C80S/C574S/S867C/ N1054C-Cas9 labelled with Cy3/Cy5) contained 50 nM Cas9, and, when present, 200 nM sgRNA and DNA unless otherwise indicated.
We observed substantial aggregation of apo-Cas9 upon 10 min incubation at 37 °C, as indicated by apparent intermolecular FRET with a single-cysteine Cas9 (C80S/C574S/S867C) that had been labelled with a mixture of Cy3-and Cy5-maleimide (data not shown). This aggregation could be completely avoided by incubating reactions for 10 min at room temperature instead, centrifuging reactions for 5 min at 16,000g and 4 °C, and using the supernatant for subsequent fluorescence measurements. This binding protocol was used for all reported FRET data. Reactions were kept at room temperature for about 10-100 min before acquisition of fluorescence spectra, and this variable time delay had no effect on the resulting data, even for reactions with catalytically active Cas9 (data not shown).
Fluorescence measurements were collected with a 3 mm path-length quartz cuvette (Hellma Analytics) and a FluoroMax-3 (HORIBA Jobin Yvon), using 5 nm slit widths and 0.2 s integration time. For each sample, two fluorescence emission spectra were recorded: (1) the sample was excited at 530 nm and emitted light was collected from 550-800 nm in 1 nm increments; and (2) the sample was excited at 630 nm and emitted light was collected from 650-800 nm in 1 nm increments. Data processing was conducted using FluorEssence software (HORIBA Jobin Yvon). Experiments were replicated at least three times, and the presented data are representative results unless stated otherwise. FRET analysis. The distance between donor and acceptor dyes can be directly calculated from the FRET efficiency, but accurately relating these variables requires knowledge of numerous complex parameters 18 . Our labelling strategy resulted in a heterogeneous mixture of unlabelled, singly-, and doubly-labelled species, further complicating the analysis. We therefore report (ratio) A as defined by refs 18, 19, whereby acceptor (Cy5) fluorescence via energy transfer is normalized against acceptor fluorescence via direct excitation (Extended Data Fig. 2d ), without pursuing a more rigorous calculation of exact distances. (Ratio) A is directly proportional to FRET efficiency, and changes in (ratio) A across different experimental conditions serve as a proxy for conformational changes.
For each FRET construct, a donor-only (Cy3-labelled) sample was prepared and its emission spectrum in the apo state after 530 nm excitation collected. This spectrum was normalized to and subtracted from each experimental emission spectrum to generate an extracted fluorescence spectrum for the acceptor via energy transfer. The integrated area under this curve from 650-800 nm was calculated and divided by the integrated area under the curve of a spectrum resulting from direct acceptor excitation at 630 nm, resulting in (ratio) A , the enhancement of acceptor fluorescence due to FRET. Raw fluorescence emission spectra presented in the figures and Extended Data figures were normalized and smoothed using the Savistsky-Golay method, and all data analysis used Prism (GraphPad Software). DNA binding and cleavage assays. Biochemical assays were conducted essentially as described 13 . Binding reactions used <0.1 nM 5′ -[ 32 P]DNA duplex substrates radiolabelled on both strands and a constant excess of 100 nM sgRNA in the presence of increasing concentrations of dCas9 or Δ HNH-Cas9. Cas9 and sgRNA were pre-incubated at 37 °C for 10 min in reaction buffer supplemented with 50 μ g ml ]-radiolabelled strand that had been annealed to a 5× molar excess of unlabelled complementary strand. Cas9 and sgRNA were pre-incubated at 37 °C for 10 min in reaction buffer before adding DNA. Cleavage reactions were performed at room temperature and contained 1 nM DNA and 100 nM Cas9-sgRNA complex. Aliquots were removed at various time points and quenched by mixing with an equal volume of formamide gel loading buffer supplemented with 50 mM EDTA. Cleavage products were resolved by 10% denaturing PAGE and visualized by phosphorimaging (GE Healthcare). Reported pseudo-first-order rate constants (k obs ) represent the population-weighted average from double-exponential fits (target strand cleavage data for proline mutants, Fig. 4e and Extended Data Fig. 7b, c) or the result from single-exponential fits (all other data). In some cases, where the observed fraction of cleaved DNA was <0.1 after 2 h, the exponential fit plateau was fixed at 0.75 to avoid overestimating the rate constant.
Experiments were replicated at least three times, and presented data are representative results unless stated otherwise. Cas9 structural analysis. All structure figures were generated using Pymol (Schrödinger). Cas9 molecules from distinct crystal structures were aligned using the RuvC and PI domains (root mean squared deviation ≈ 0.5-0.7). To generate the modelled docked state for the HNH domain ( Fig. 2a and Extended Data Fig. 3 ), nucleotides 12-13 of chain D of PDB 2QNC (endonuclease-VII-DNA structure) were first aligned to nucleotides 11-12 of chain C of PDB 4UN3 (sgRNA/DNAbound Cas9 structure). A copy of the Cas9 HNH domain from PDB 4UN3 was then aligned to chain A of PDB 2QNC. Conservation rendering was done using a multiple sequence alignment of 250 Cas9 homologues and the ConSurf server 
